| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/EURHEARTJ/EHR048 |
| P698 | PubMed publication ID | 21406440 |
| P50 | author | Vera Regitz-Zagrosek | Q21264842 |
| Gerard Pasterkamp | Q57298458 | ||
| Menno V Huisman | Q89473202 | ||
| Hugo ten Cate | Q37384164 | ||
| Yvonne T van der Schouw | Q37390536 | ||
| P2093 | author name string | Eva Swahn | |
| Angela H E M Maas | |||
| Peter M Nilsson | |||
| Yolande E Appelman | |||
| Marco Stramba-Badiale | |||
| Karin Eizema | |||
| Hans C G Stam | |||
| P2860 | cites work | Symptom Presentation of Women With Acute Coronary Syndromes | Q22253061 |
| Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991 | Q22306385 | ||
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
| Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries | Q46088365 | ||
| Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials). | Q46387239 | ||
| Hemostatic factors and estrogen during the menopausal transition | Q46402674 | ||
| Menopausal complaints, oestrogens, and heart disease risk: an explanation for discrepant findings on the benefits of post-menopausal hormone therapy | Q46462927 | ||
| Menopausal complaints are associated with cardiovascular risk factors | Q46662635 | ||
| Effect of menopause on platelet activation markers determined by flow cytometry | Q46825731 | ||
| Menopause and the characteristics of the large arteries in a population study | Q49034543 | ||
| Estrogen replacement and brachial artery flow-mediated vasodilation in older women | Q50688484 | ||
| Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women | Q50882502 | ||
| Cardiac-resynchronization therapy for the prevention of heart-failure events. | Q51136225 | ||
| Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. | Q51656261 | ||
| Intravascular ultrasonic study of gender differences in ruptured coronary plaque morphology and its associated clinical presentation. | Q51746215 | ||
| Gender differences in the management and clinical outcome of stable angina. | Q51820934 | ||
| Pre-morbid psychiatric and cardiovascular diseases in apical ballooning syndrome (tako-tsubo/stress-induced cardiomyopathy): potential pre-disposing factors? | Q51855519 | ||
| Coronary heart disease in women: update 2008. | Q51899702 | ||
| Sex bias in trials and treatment must end. | Q53068521 | ||
| Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee | Q53596045 | ||
| The Yentl syndrome. | Q55053011 | ||
| Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events | Q57243438 | ||
| Age at Natural Menopause and Risk of Cardiovascular Disease | Q57750838 | ||
| Impact of race and gender on antithrombotic therapy | Q57764560 | ||
| Heart Disease Risk Determines Menopausal Age Rather Than the Reverse | Q57910217 | ||
| Age at Menopause, Cause-Specific Mortality and Total Life Expectancy | Q57910231 | ||
| Sex differences in mortality following acute coronary syndromes | Q37424804 | ||
| Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project | Q37436667 | ||
| Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. | Q37461889 | ||
| Women and ischemic heart disease: evolving knowledge. | Q37462134 | ||
| Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis | Q37493828 | ||
| Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. | Q37602789 | ||
| Gender differences in risk factors for coronary heart disease | Q37629321 | ||
| Representation of women in randomized clinical trials of cardiovascular disease prevention | Q37693535 | ||
| Sex and gender differences in myocardial hypertrophy and heart failure | Q37766058 | ||
| Prolactin: a new therapeutic target in peripartum cardiomyopathy | Q37775437 | ||
| Preeclampsia as a female-specific risk factor for chronic hypertension | Q37787579 | ||
| Diagnosis and treatment of heart disease: are women different from men? | Q37815916 | ||
| Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial | Q38948446 | ||
| Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study | Q39881547 | ||
| Sex-specific trends in midlife coronary heart disease risk and prevalence | Q39935448 | ||
| Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators | Q42606103 | ||
| Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event | Q42855242 | ||
| Regression of myocardial hypertrophy after aortic valve replacement: faster in women? | Q42908777 | ||
| Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). | Q42923039 | ||
| Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors | Q43157211 | ||
| Stress reduction prolongs life in women with coronary disease: the Stockholm Women's Intervention Trial for Coronary Heart Disease (SWITCHD). | Q43209333 | ||
| Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women | Q43623880 | ||
| Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis | Q44086539 | ||
| Gender perspective on risk factors, coronary lesions and long-term outcome in young patients with ST-elevation myocardial infarction | Q44245198 | ||
| Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study | Q44307928 | ||
| Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). | Q44936581 | ||
| National study of physician awareness and adherence to cardiovascular disease prevention guidelines | Q28217358 | ||
| A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women | Q28218670 | ||
| Large and small vessels atherosclerosis: similarities and differences | Q28244288 | ||
| Trends in prevalence and outcome of heart failure with preserved ejection fraction | Q28252937 | ||
| Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction | Q28269750 | ||
| Psychosocial Factors in the Development of Heart Disease in Women: Current Research and Future Directions | Q28384482 | ||
| Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
| Final report on the aspirin component of the ongoing Physicians' Health Study | Q29619461 | ||
| Angina with "normal" coronary arteries: a changing philosophy. | Q30350043 | ||
| Proceedings from the scientific symposium: Sex differences in cardiovascular disease and implications for therapies | Q30432160 | ||
| Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). | Q31829434 | ||
| Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis | Q31928210 | ||
| Coronary intervention in 2009: are women no different than men? | Q33520616 | ||
| Female sex and estrogen receptor-beta attenuate cardiac remodeling and apoptosis in pressure overload | Q33550675 | ||
| Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation | Q33610895 | ||
| The protective effects of estrogen on the cardiovascular system | Q33654314 | ||
| Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure | Q33710663 | ||
| Triggers, targets and treatments for thrombosis | Q33765444 | ||
| Smoking and risk of myocardial infarction in women and men: longitudinal population study | Q33773164 | ||
| Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? | Q33797766 | ||
| The gene expression profile of patients with new-onset heart failure reveals important gender-specific differences | Q33849050 | ||
| Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women | Q33879112 | ||
| Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. | Q33967744 | ||
| Race, gender, and mortality in adults > or =65 years of age with incident heart failure (from the Cardiovascular Health Study) | Q34004581 | ||
| Impact of high-normal blood pressure on the risk of cardiovascular disease | Q34109606 | ||
| The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles Atherosclerosis Study. | Q34113174 | ||
| Thyroid replacement therapy and heart failure | Q34128068 | ||
| Early atherosclerosis exhibits an enhanced procoagulant state. | Q34130566 | ||
| Autonomic function and prothrombotic activity in women after an acute coronary event | Q34150160 | ||
| Estrogen plus progestin and the risk of coronary heart disease | Q34220432 | ||
| Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. | Q34251047 | ||
| Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. | Q34423669 | ||
| The role of social support in health status and depressive symptoms after acute myocardial infarction: evidence for a stronger relationship among women | Q34471048 | ||
| Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants | Q34504289 | ||
| Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms | Q34507733 | ||
| Missed diagnoses of acute cardiac ischemia in the emergency department. | Q34508319 | ||
| Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. | Q34520790 | ||
| The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis | Q34532092 | ||
| Estrogen replacement therapy, atherosclerosis, and vascular function | Q34541886 | ||
| EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population | Q34568746 | ||
| Role of gender in heart failure with normal left ventricular ejection fraction | Q34573556 | ||
| Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update | Q34575872 | ||
| Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists | Q34581269 | ||
| Risk factors for myocardial infarction in women and men: insights from the INTERHEART study | Q34589355 | ||
| Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis | Q34708320 | ||
| Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence | Q34748119 | ||
| ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology | Q34830023 | ||
| Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses | Q34897462 | ||
| Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study | Q35754796 | ||
| Clinical epidemiology of heart failure | Q35954269 | ||
| The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology | Q36056219 | ||
| Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study | Q36255692 | ||
| Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology | Q36416017 | ||
| Therapeutic implications of the gender-specific aspects of cardiovascular disease | Q36467824 | ||
| Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute spons | Q36536790 | ||
| Coronary microvascular dysfunction | Q36741793 | ||
| European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by rep | Q36921892 | ||
| Early breast cancer therapy and cardiovascular injury. | Q36962419 | ||
| Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease | Q37044313 | ||
| Menopause and hypertension: an age-old debate | Q37079638 | ||
| Current diagnostic concepts to detect coronary artery disease in women | Q37083957 | ||
| Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries | Q37112357 | ||
| Aetiology and risk factors of peripartum cardiomyopathy: a systematic review | Q37250325 | ||
| P433 | issue | 11 | |
| P921 | main subject | cardiovascular disease | Q389735 |
| workshop | Q27556165 | ||
| cardiovascular disease in women | Q105047283 | ||
| P304 | page(s) | 1362-1368 | |
| P577 | publication date | 2011-03-15 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | Red alert for women's heart: the urgent need for more research and knowledge on cardiovascular disease in women: proceedings of the workshop held in Brussels on gender differences in cardiovascular disease, 29 September 2010. | |
| P478 | volume | 32 |
| Q38961330 | Are elderly and women under-represented in cardiovascular clinical trials? Implication for treatment. |
| Q33655700 | Association of body mass index with risk of acute myocardial infarction and mortality in Norwegian male and female patients with suspected stable angina pectoris: a prospective cohort study |
| Q89881661 | Association of gout with CAD and effect of antigout therapy on CVD risk among gout patients |
| Q92899078 | Biological normalcy |
| Q64087698 | Breastfeeding and Cardiovascular Disease Hospitalization and Mortality in Parous Women: Evidence From a Large Australian Cohort Study |
| Q38349478 | Cardiovascular disease risk in women with a history of spontaneous preterm delivery: A systematic review and meta-analysis |
| Q38261525 | Cardiovascular disease risk in women with premature ovarian insufficiency: A systematic review and meta-analysis |
| Q30582667 | Cardiovascular risk in women attending primary care centres: baseline data of the EVA study |
| Q33926224 | Clinical and gender differences in heart transplant recipients in the NEW HEART study |
| Q48103834 | Combining value of information analysis and ethical argumentation in decisions on participation of vulnerable patients in clinical research. |
| Q44878331 | Comparison of different cardiac risk scores for coronary artery disease in symptomatic women: do female-specific risk factors matter? |
| Q36319716 | Computed tomography coronary angiography accuracy in women and men at low to intermediate risk of coronary artery disease |
| Q42149960 | Conflicts of interest in medicine and science |
| Q63812071 | Determinants of coronary artery disease risk factor management across three world regions |
| Q53632178 | Differences in patient outcomes after conventional versus real time perfusion stress echocardiography in men versus women: a prospective randomised trial. |
| Q36805845 | Doubly blind: a systematic review of gender in randomised controlled trials. |
| Q90782102 | Early life feeding and current dietary patterns are associated with biomarkers of glucose and lipid metabolism in young women from the Nutritionist's Health Study |
| Q64977737 | Effects of lifestyle-related factors on ischemic heart disease according to body mass index and fasting blood glucose levels in Korean adults. |
| Q28544671 | Effects of treatment with zofenopril in men and women with acute myocardial infarction: gender analysis of the SMILE Program |
| Q94586057 | Empower Women in Healthcare to move Women's Health forward |
| Q37359230 | Evolution of cardiovascular risk factors and ischemic heart disease in an elderly urban Romanian population over the course of 1 year |
| Q38597925 | Exposure to Violence and Carotid Artery Intima-Media Thickness in Mexican Women |
| Q34439065 | Gender comparisons in non-acute cardiac symptom recognition and subsequent help-seeking decisions: a mixed methods study protocol |
| Q39922080 | Gender differences for uric acid as predictor of hard events in patients referred for coronary angiography. |
| Q91270618 | Gender differences in Egyptian patients hospitalized with heart failure: insights from the European Society of Cardiology Heart Failure Long-Term Registry |
| Q44391988 | Gender differences in acute and chronic pain conditions. Implications for diagnosis and therapy |
| Q60920331 | Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure |
| Q35190072 | Gender differences in ocular blood flow |
| Q39193538 | Gender differences in the effects of cardiovascular drugs |
| Q51272802 | Gender-related differences in hospitalized heart failure patients. |
| Q39175116 | Hypertension and pregnancy: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology |
| Q36443810 | Hypertension in women: latest findings and clinical implications |
| Q30234825 | Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women? |
| Q21296696 | Inhibition of the Mitochondrial Permeability Transition for Cytoprotection: Direct versus Indirect Mechanisms |
| Q39175806 | Long-Term Hormone Replacement Therapy Is Associated with Low Coronary Artery Calcium Levels in a Cohort of Older Women: The Age, Gene/Environment Susceptibility-Reykjavik Study |
| Q38627804 | Management of Indigenous patients presenting with non ST-segment elevation acute coronary syndrome in South Australia: a retrospective cohort study. |
| Q45979909 | Outcomes in Women and Minorities Compared With White Men 1 Year After Everolimus-Eluting Stent Implantation: Insights and Results From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study Pooled Analysis. |
| Q55032796 | Predictors of subclinical carotid atherosclerosis in middle-aged women. |
| Q41604789 | Prenatal and maternal characteristics and later risk for coronary heart disease among women |
| Q40201605 | Prevalence of chronic kidney disease and its determinants in coronary heart disease patients in 24 European countries: Insights from the EUROASPIRE IV survey of the European Society of Cardiology |
| Q50796047 | Prognostic role of heart rate in patients referred for coronary angiography: age and sex differences |
| Q33850924 | Reduced vasodilator function following acute resistance exercise in obese women |
| Q38283099 | Regulation of coronary blood flow in health and ischemic heart disease |
| Q53687323 | Risk Factor Burden, Heart Failure, and Survival in Women of Different Ethnic Groups: Insights From the Women's Health Initiative. |
| Q36633645 | Sex Differences in Outcomes Following Percutaneous Coronary Intervention According to Age. |
| Q35623424 | Sex Differences in Presynaptic Density and Neurogenesis in Middle-Aged ApoE4 and ApoE Knockout Mice |
| Q90554052 | Sex Differences in the Coronary System |
| Q38182007 | Sex differences in cardiomyopathies |
| Q47145686 | Sex differences in risk factor management of coronary heart disease across three regions |
| Q37651567 | Sex hormone therapy and progression of cardiovascular disease in menopausal women |
| Q61795657 | Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register |
| Q96955188 | Sex-Specific Effects of the Nlrp3 Inflammasome on Atherogenesis in LDL Receptor-Deficient Mice |
| Q38938316 | Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study |
| Q45141283 | Sex-specific acute heart failure phenotypes and outcomes from PROTECT. |
| Q33577443 | Shared biomarkers between female diastolic heart failure and pre-eclampsia: a systematic review and meta-analysis |
| Q23920904 | Social disparities in heart disease risk and survivor bias among autoworkers: an examination based on survival models and g-estimation |
| Q37140914 | Temporal trends in treatment of ST-elevation myocardial infarction among men and women in Switzerland between 1997 and 2011. |
| Q38228764 | The female human heart at rest and during exercise: a review |
| Q91772616 | The impact of comorbidities on mortality among men and women with COPD: report from the OLIN COPD study |
| Q48024750 | The impact of exercise-only-based rehabilitation on depression and anxiety in patients after myocardial infarction |
| Q41983713 | Uric Acid for Cardiovascular Risk: Dr. Jekyll or Mr. Hide? |
| Q63871529 | Vascular extracellular vesicles in comorbidities of heart failure with preserved ejection fraction in men and women: The hidden players. A mini review |
| Q37983641 | Why sex matters: the biological mechanisms of cardiovascular disease. |
| Q36398736 | Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry |
| Q46063479 | Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting xience V stents: insights from the gender-stratified, randomized, controlled TWENTE trial. |
| Q61875211 | Women with Stable Angina Pectoris and No Obstructive Coronary Artery Disease: Closer to a Diagnosis |
Search more.